Figure 5
Figure 5. CD27+CD21low, compared with CD27+CD21high, B cells have attenuated Ca2+ responses after BCR cross-linking. Analyses of B cells from one healthy volunteer (ECH 503), 2 HCV+MC− patients (ECH 530 and ECH 537), and 5 HCV+MC+ patients (ECH 546, ECH 559, 110, LDU 125, and 1931) are shown. PBMCs from 1931 and LDU 125 were collected 4 and 10 months, respectively, after the cells collected for the microarray and primary immunophenotyping experiments. (Left panels) CD27 and CD21 staining of IgG− B cells. Indo-1-AM-loaded cells were stained with anti-CD19, anti-IgG, anti-CD27, and anti-CD21, warmed to 37°C, and, after establishing a baseline for 30 seconds, stimulated with 10 μg/mL goat F(ab′)2 anti–human IgM. Kinetic graphs represent ratios of bound/unbound Indo-1 over time for CD27+CD21high, CD27+CD21low, CD27−CD21high, and CD27−CD21low B-cell populations. Single arrows indicate injection of F(ab′)2 anti–human IgM; and double arrow, injection of 10 μg/mL ionomycin.

CD27+CD21low, compared with CD27+CD21high, B cells have attenuated Ca2+ responses after BCR cross-linking. Analyses of B cells from one healthy volunteer (ECH 503), 2 HCV+MC patients (ECH 530 and ECH 537), and 5 HCV+MC+ patients (ECH 546, ECH 559, 110, LDU 125, and 1931) are shown. PBMCs from 1931 and LDU 125 were collected 4 and 10 months, respectively, after the cells collected for the microarray and primary immunophenotyping experiments. (Left panels) CD27 and CD21 staining of IgG B cells. Indo-1-AM-loaded cells were stained with anti-CD19, anti-IgG, anti-CD27, and anti-CD21, warmed to 37°C, and, after establishing a baseline for 30 seconds, stimulated with 10 μg/mL goat F(ab′)2 anti–human IgM. Kinetic graphs represent ratios of bound/unbound Indo-1 over time for CD27+CD21high, CD27+CD21low, CD27CD21high, and CD27CD21low B-cell populations. Single arrows indicate injection of F(ab′)2 anti–human IgM; and double arrow, injection of 10 μg/mL ionomycin.

Close Modal

or Create an Account

Close Modal
Close Modal